Suparma Tbk
PT Suparma Tbk manufactures and sells paper and related paper products in Indonesia. The company's paper products include laminated wrapping and brown Kraft papers; sandwiched ribbed Kraft recycle papers; and coated duplex boards. It also offers bathroom, facial, napkin, and carrier tissues; cocktail, dinner, and luncheon napkins. In addition, the company provides hand, hand roll, industrial and … Read more
Suparma Tbk (SPMA) - Net Assets
Latest net assets as of June 2025: Rp2.44 Trillion IDR
Based on the latest financial reports, Suparma Tbk (SPMA) has net assets worth Rp2.44 Trillion IDR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp3.50 Trillion) and total liabilities (Rp1.07 Trillion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rp2.44 Trillion |
| % of Total Assets | 69.59% |
| Annual Growth Rate | 8.6% |
| 5-Year Change | 55.72% |
| 10-Year Change | 216.83% |
| Growth Volatility | 31.05 |
Suparma Tbk - Net Assets Trend (2000–2024)
This chart illustrates how Suparma Tbk's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Suparma Tbk (2000–2024)
The table below shows the annual net assets of Suparma Tbk from 2000 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Rp2.38 Trillion | +2.81% |
| 2023-12-31 | Rp2.32 Trillion | +8.07% |
| 2022-12-31 | Rp2.15 Trillion | +18.22% |
| 2021-12-31 | Rp1.82 Trillion | +18.55% |
| 2020-12-31 | Rp1.53 Trillion | +11.17% |
| 2019-12-31 | Rp1.38 Trillion | +9.80% |
| 2018-12-31 | Rp1.25 Trillion | +7.03% |
| 2017-12-31 | Rp1.17 Trillion | +8.62% |
| 2016-12-31 | Rp1.08 Trillion | +43.37% |
| 2015-12-31 | Rp752.68 Billion | -6.45% |
| 2014-12-31 | Rp804.60 Billion | +6.49% |
| 2013-12-31 | Rp755.53 Billion | -3.07% |
| 2012-12-31 | Rp779.49 Billion | +3.73% |
| 2011-12-31 | Rp751.46 Billion | +4.60% |
| 2010-12-31 | Rp718.39 Billion | +4.30% |
| 2009-12-31 | Rp688.76 Billion | +4.07% |
| 2008-12-31 | Rp661.83 Billion | -2.12% |
| 2007-12-31 | Rp676.13 Billion | +50.67% |
| 2006-12-31 | Rp448.74 Billion | +10.64% |
| 2005-12-31 | Rp405.57 Billion | +138.69% |
| 2004-12-31 | Rp169.92 Billion | -23.38% |
| 2003-12-31 | Rp221.78 Billion | +5.33% |
| 2002-12-31 | Rp210.55 Billion | -21.43% |
| 2001-12-31 | Rp267.98 Billion | -18.52% |
| 2000-12-31 | Rp328.90 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Suparma Tbk's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 102917748900000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rp1.03 Trillion | 43.16% |
| Common Stock | Rp1.26 Trillion | 52.91% |
| Other Comprehensive Income | Rp89.55 Billion | 3.76% |
| Other Components | Rp4.32 Billion | 0.18% |
| Total Equity | Rp2.38 Trillion | 100.00% |
Suparma Tbk Competitors by Market Cap
The table below lists competitors of Suparma Tbk ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
i2S SA
PA:ALI2S
|
$3.21 Million |
|
Argha Karya Prima Ind Tbk
JK:AKPI
|
$3.21 Million |
|
Cre8 Enterprise Limited Class A Ordinary Shares
NASDAQ:CRE
|
$3.21 Million |
|
Inocycle Technology Tbk PT
JK:INOV
|
$3.21 Million |
|
Caely Holdings Bhd
KLSE:7154
|
$3.21 Million |
|
Witbe Net SA
PA:ALWIT
|
$3.21 Million |
|
SpectraCure AB
ST:SPEC
|
$3.21 Million |
|
Polychem Indonesia Tbk
JK:ADMG
|
$3.21 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Suparma Tbk's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,319,418,975,917 to 2,384,681,865,000, a change of 65,262,889,083 (2.8%).
- Net income of 104,838,994,000 contributed positively to equity growth.
- Dividend payments of 37,759,958,000 reduced retained earnings.
- Other comprehensive income increased equity by 19,501,298,966.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rp104.84 Billion | +4.4% |
| Dividends Paid | Rp37.76 Billion | -1.58% |
| Other Comprehensive Income | Rp19.50 Billion | +0.82% |
| Other Changes | Rp-21.32 Billion | -0.89% |
| Total Change | Rp- | 2.81% |
Book Value vs Market Value Analysis
This analysis compares Suparma Tbk's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.28x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.63x to 0.28x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | Rp342.15 | Rp214.00 | x |
| 2017-12-31 | Rp371.65 | Rp214.00 | x |
| 2018-12-31 | Rp397.78 | Rp214.00 | x |
| 2019-12-31 | Rp436.75 | Rp214.00 | x |
| 2020-12-31 | Rp485.53 | Rp214.00 | x |
| 2021-12-31 | Rp660.73 | Rp214.00 | x |
| 2022-12-31 | Rp680.48 | Rp214.00 | x |
| 2023-12-31 | Rp735.37 | Rp214.00 | x |
| 2024-12-31 | Rp756.06 | Rp214.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Suparma Tbk utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.40%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.84%
- • Asset Turnover: 0.80x
- • Equity Multiplier: 1.42x
- Recent ROE (4.40%) is below the historical average (6.33%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | 5.06% | 2.39% | 0.46x | 4.65x | Rp-10.95 Billion |
| 2005 | 2.01% | 1.41% | 0.44x | 3.26x | Rp-32.41 Billion |
| 2006 | 5.19% | 3.38% | 0.50x | 3.08x | Rp-21.58 Billion |
| 2007 | 4.05% | 3.36% | 0.54x | 2.22x | Rp-40.22 Billion |
| 2009 | 3.91% | 2.64% | 0.71x | 2.08x | Rp-41.94 Billion |
| 2010 | 4.12% | 2.55% | 0.78x | 2.07x | Rp-42.22 Billion |
| 2011 | 4.40% | 2.78% | 0.77x | 2.07x | Rp-42.07 Billion |
| 2012 | 5.12% | 3.13% | 0.77x | 2.14x | Rp-38.06 Billion |
| 2014 | 6.04% | 3.13% | 0.74x | 2.60x | Rp-31.86 Billion |
| 2015 | -5.66% | -2.63% | 0.74x | 2.90x | Rp-117.87 Billion |
| 2016 | 7.51% | 4.19% | 0.90x | 2.00x | Rp-26.85 Billion |
| 2017 | 7.87% | 4.41% | 0.96x | 1.86x | Rp-24.94 Billion |
| 2018 | 6.55% | 3.44% | 1.05x | 1.82x | Rp-43.23 Billion |
| 2019 | 9.51% | 5.21% | 1.06x | 1.72x | Rp-6.75 Billion |
| 2020 | 10.61% | 7.55% | 0.93x | 1.51x | Rp9.39 Billion |
| 2021 | 16.21% | 10.53% | 1.02x | 1.51x | Rp112.78 Billion |
| 2022 | 15.66% | 10.71% | 0.97x | 1.51x | Rp121.51 Billion |
| 2023 | 7.70% | 6.72% | 0.80x | 1.42x | Rp-53.28 Billion |
| 2024 | 4.40% | 3.84% | 0.80x | 1.42x | Rp-133.63 Billion |
Industry Comparison
This section compares Suparma Tbk's net assets metrics with peer companies in the Paper & Paper Products industry.
Industry Context
- Industry: Paper & Paper Products
- Average net assets among peers: $488,409,993,982
- Average return on equity (ROE) among peers: 4.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Suparma Tbk (SPMA) | Rp2.44 Trillion | 5.06% | 0.44x | $3.21 Million |
| Alkindo Naratama Tbk (ALDO) | $229.42 Billion | 5.74% | 1.17x | $23.12 Million |
| Indah Kiat Pulp & Paper Tbk (INKP) | $2.82 Billion | 7.19% | 1.44x | $1.35 Billion |
| Toba Pulp Lestari Tbk (INRU) | $2.16 Trillion | 2.52% | 2.02x | $3.76 Million |
| Inter-Delta Tbk (INTD) | $47.12 Billion | 3.57% | 0.06x | $1.05 Million |
| Pabrik Kertas Tjiwi Kimia Tbk (TKIM) | $798.26 Million | 3.38% | 2.26x | $584.28 Million |